AstraZeneca PLC is 142.1x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($286.27 B vs $2.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AUPH | AZN |
|---|---|---|
| Market cap | $2.01 B | $286.27 B |
| US-listed rank | #2094 | #45 |
| Revenue (latest FY) | $283.06M | - |
| Net income (latest FY) | $287.20M | - |
| Net margin | 101.5% | - |
| P/E (trailing FY) | 7.0 | - |
| SEC filings | 595 | 1,004 |
AstraZeneca PLC is 142.1x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($286.27 B vs $2.01 B).
Full pages: Aurinia Pharmaceuticals Inc. and AstraZeneca PLC, or browse the full rankings.